Brandy Norwood was the recipient of an awesome Christmas gift this year…a diamond engagement ring! The 33-year-old singer and “Moesha” star is engaged to marry music mogul Ryan Press! A source revealed the Christmas proposal, stating, “They are thrilled and happy and Brandy feels this is so right.” Brandy had made no secret of her ...
Drug shortage linked to greater risk of relapse in young Hodgkin lymphoma patientsPublic release date: 26-Dec-2012 [ | E-mail | Share ]
Contact: Summer Freeman media@stjude.org 901-297-9861 St. Jude Children's Research Hospital
National study connects higher rates of relapse in pediatric cancer patients to drug shortage, offering first example of patients hurt by shortages and renewing calls to protect patient access to lifesaving treatments
A national drug shortage has been linked to a higher rate of relapse among children, teenagers and young adults with Hodgkin lymphoma enrolled in a national clinical trial, according to research led by St. Jude Children's Research Hospital.
Estimated two-year cancer-free survival for patients enrolled in the study fell from 88 to 75 percent after the drug cyclophosphamide was substituted for mechlorethamine for treatment of patients with intermediate- or high-risk Hodgkin lymphoma. The study was launched before the drug shortages began. The change occurred after a mechlorethamine shortage that began in 2009. No study patients have died, but those who relapsed received additional intensive therapy that is associated with higher odds for infertility and other health problems later.
An analysis comparing how patients in each group were faring two years after their cancer diagnoses appears in the December 27 edition of the New England Journal of Medicine. The report provides the first evidence of a drug shortage adversely impacting treatment outcomes in specific patients. St. Jude led the study for a national group that includes the Stanford University School of Medicine and Lucile Packard Children's Hospital at Stanford; Dana-Farber Cancer Institute and Boston Children's Hospital; Massachusetts General Hospital; and Maine Medical Center.
In recent years, many patients and caregivers have had their medical care complicated by drug shortages, primarily of generic injectable drugs like mechlorethamine. Mechlorethamine, which has been used in cancer treatment since the 1960s, has only recently become available again.
Cyclophosphamide has been widely used in treatment of both adults and children with Hodgkin lymphoma. Based on earlier studies, the drug was considered a safe and effective alternative to mechlorethamine.
"This is a devastating example of how drug shortages affect patients and why these shortages must be prevented," said Monika Metzger, M.D., an associate member of the St. Jude Department of Oncology and the study's principal investigator. "Our results demonstrate that, for many chemotherapy drugs, there are no adequate substitute drugs available."
Past shortages have been resolved in a variety of ways and always before a drug substitution became necessary, said Michael Link, M.D., the senior author of the new report. Link is a professor of pediatrics in hematology-oncology at Stanford and a member of the pediatric hematology-oncology service at Packard Children's Hospital. He is also immediate past president of the American Society of Clinical Oncology. "This puts a face on the problem of drug shortages and shows that the problem is real, not theoretical. This is about a curative therapy that we were unable to administer because the drug we needed was not available," Link said. "Despite heroic efforts by the drug shortage office of the Food and Drug Administration to solve the shortages of a number of medically necessary drugs, it is clear that patients are still suffering from the unavailability of life-saving drugs. A more systematic solution to the problem is needed."
Amy Billett, M.D., a pediatric oncologist at Dana-Farber/Children's Hospital Cancer Center in Boston is the paper's other author.
Hodgkin lymphoma is a cancer of the lymph system and accounts for about 6 percent of childhood cancers. In the United States, about 90 percent of patients will become long-term survivors. Working as the Pediatric Hodgkin Consortium, in 2002 the five institutions involved in this study adopted a seven-drug chemotherapy regimen that included mechlorethamine for the treatment of high-risk pediatric patients. The goal was to preserve high cure rates, but to reduce the risk of second cancers, infertility and other problems associated with the earlier treatments. In 2006, a parallel study was opened for patients with intermediate-risk disease. The risk categories reflect the extent to which cancer has spread, particularly the number and location of lymph nodes involved, plus the presence of unfavorable symptoms of fever, night sweats and unexplained weight loss.
The strategy involved 12 weeks of the seven-drug chemotherapy regimen. Patients also received radiotherapy with the dose based on their response to chemotherapy. When mechlorethamine became unavailable, the protocol was revised to allow the cyclophosphamide substitution.
Outcomes for cancer patients are often measured in terms of cancer-free survival, which is the number of years patients remain free of the disease. When researchers assessed the substitution's impact, they found that estimated disease-free survival was 88 percent for the 181 patients whose treatment included mechlorethamine. It was 75 percent for the 40 patients who received cyclophosphamide instead. The difference led researchers to stop enrolling new patients in the trials.
"We can think of no credible explanation for this dramatic difference in event-free survival other than the drug substitution," the researchers noted. The analysis found that, as a group, patients who received cyclophosphamide had fewer unfavorable symptoms and were more likely to have intermediate-risk, rather than high-risk Hodgkin lymphoma. The patients ranged in age from 3 to 21. Half were age 14 or younger.
Patients who relapsed received additional therapy. Researchers said it is too soon to know if these patients will have the same long-term survival rates as those whose did not relapse. The additional treatment included intensive chemotherapy followed by a stem cell transplant using the patient's own blood-producing stem cells.
###
St. Jude Children's Research Hospital
Since opening 50 years ago, St. Jude Children's Research Hospital has played a pivotal role in pushing overall U.S. pediatric cancer survival rates from 20 to 80 percent. Founded by the late entertainer Danny Thomas, St. Jude is the first and only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. St. Jude is also a leader in research and treatment of life-threatening blood disorders and infectious diseases in children. No family ever pays St. Jude for the care their child receives. To learn more, visit www.stjude.org. Follow us on Twitter @StJudeResearch.
The Stanford University School of Medicine
The Stanford University School of Medicine consistently ranks among the nation's top medical schools, integrating research, medical education, patient care and community service. For more news about the school, please visit http://mednews.stanford.edu.
Lucile Packard Children's Hospital
Lucile Packard Children's Hospital at Stanford is an internationally recognized 311-bed hospital, research center and leading regional medical network providing the full complement of services for the health of children and expectant mothers. In partnership with the Stanford University School of Medicine, our world-class doctors and nurses deliver innovative, family-centered care in every pediatric and obstetric specialty, tailored to every patient. Packard Children's is annually ranked as one of the nation's best pediatric hospitals by U.S. News & World Report and is the only Northern California children's hospital with specialty programs ranked in the U.S. News Top 10. Learn more about us at www.lpch.org and about our continuing growth at growing.lpch.org. Like us on Facebook, watch us on YouTube and follow us on Twitter.
Dana-Farber/Children's Hospital Cancer Center
Since 1947, Boston Children's Hospital and Dana-Farber Cancer Institute have provided comprehensive care for children and adolescents with cancer through Dana-Farber/Children's Hospital Cancer Center. The two Harvard Medical School affiliates share a clinical staff that delivers inpatient care at Boston Children's and outpatient therapies at Dana-Farber's Jimmy Fund Clinic. The Boston Children's inpatient pediatric cancer service has 33 beds, including 13 designated for stem cell transplant patients.
Stanford/Packard Children's Media Relations Contacts:
Stanford University School of Medicine news pager
(650) 723-8222, pager ID #25314
Robert Dicks
(650) 497-8364
rdicks@lpch.org
Dana-Farber/Children's Hospital Cancer Center Media Relations Contact:
Bill Schaller
(617) 632-5357
william_schaller@dfci.harvard.edu
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Drug shortage linked to greater risk of relapse in young Hodgkin lymphoma patientsPublic release date: 26-Dec-2012 [ | E-mail | Share ]
Contact: Summer Freeman media@stjude.org 901-297-9861 St. Jude Children's Research Hospital
National study connects higher rates of relapse in pediatric cancer patients to drug shortage, offering first example of patients hurt by shortages and renewing calls to protect patient access to lifesaving treatments
A national drug shortage has been linked to a higher rate of relapse among children, teenagers and young adults with Hodgkin lymphoma enrolled in a national clinical trial, according to research led by St. Jude Children's Research Hospital.
Estimated two-year cancer-free survival for patients enrolled in the study fell from 88 to 75 percent after the drug cyclophosphamide was substituted for mechlorethamine for treatment of patients with intermediate- or high-risk Hodgkin lymphoma. The study was launched before the drug shortages began. The change occurred after a mechlorethamine shortage that began in 2009. No study patients have died, but those who relapsed received additional intensive therapy that is associated with higher odds for infertility and other health problems later.
An analysis comparing how patients in each group were faring two years after their cancer diagnoses appears in the December 27 edition of the New England Journal of Medicine. The report provides the first evidence of a drug shortage adversely impacting treatment outcomes in specific patients. St. Jude led the study for a national group that includes the Stanford University School of Medicine and Lucile Packard Children's Hospital at Stanford; Dana-Farber Cancer Institute and Boston Children's Hospital; Massachusetts General Hospital; and Maine Medical Center.
In recent years, many patients and caregivers have had their medical care complicated by drug shortages, primarily of generic injectable drugs like mechlorethamine. Mechlorethamine, which has been used in cancer treatment since the 1960s, has only recently become available again.
Cyclophosphamide has been widely used in treatment of both adults and children with Hodgkin lymphoma. Based on earlier studies, the drug was considered a safe and effective alternative to mechlorethamine.
"This is a devastating example of how drug shortages affect patients and why these shortages must be prevented," said Monika Metzger, M.D., an associate member of the St. Jude Department of Oncology and the study's principal investigator. "Our results demonstrate that, for many chemotherapy drugs, there are no adequate substitute drugs available."
Past shortages have been resolved in a variety of ways and always before a drug substitution became necessary, said Michael Link, M.D., the senior author of the new report. Link is a professor of pediatrics in hematology-oncology at Stanford and a member of the pediatric hematology-oncology service at Packard Children's Hospital. He is also immediate past president of the American Society of Clinical Oncology. "This puts a face on the problem of drug shortages and shows that the problem is real, not theoretical. This is about a curative therapy that we were unable to administer because the drug we needed was not available," Link said. "Despite heroic efforts by the drug shortage office of the Food and Drug Administration to solve the shortages of a number of medically necessary drugs, it is clear that patients are still suffering from the unavailability of life-saving drugs. A more systematic solution to the problem is needed."
Amy Billett, M.D., a pediatric oncologist at Dana-Farber/Children's Hospital Cancer Center in Boston is the paper's other author.
Hodgkin lymphoma is a cancer of the lymph system and accounts for about 6 percent of childhood cancers. In the United States, about 90 percent of patients will become long-term survivors. Working as the Pediatric Hodgkin Consortium, in 2002 the five institutions involved in this study adopted a seven-drug chemotherapy regimen that included mechlorethamine for the treatment of high-risk pediatric patients. The goal was to preserve high cure rates, but to reduce the risk of second cancers, infertility and other problems associated with the earlier treatments. In 2006, a parallel study was opened for patients with intermediate-risk disease. The risk categories reflect the extent to which cancer has spread, particularly the number and location of lymph nodes involved, plus the presence of unfavorable symptoms of fever, night sweats and unexplained weight loss.
The strategy involved 12 weeks of the seven-drug chemotherapy regimen. Patients also received radiotherapy with the dose based on their response to chemotherapy. When mechlorethamine became unavailable, the protocol was revised to allow the cyclophosphamide substitution.
Outcomes for cancer patients are often measured in terms of cancer-free survival, which is the number of years patients remain free of the disease. When researchers assessed the substitution's impact, they found that estimated disease-free survival was 88 percent for the 181 patients whose treatment included mechlorethamine. It was 75 percent for the 40 patients who received cyclophosphamide instead. The difference led researchers to stop enrolling new patients in the trials.
"We can think of no credible explanation for this dramatic difference in event-free survival other than the drug substitution," the researchers noted. The analysis found that, as a group, patients who received cyclophosphamide had fewer unfavorable symptoms and were more likely to have intermediate-risk, rather than high-risk Hodgkin lymphoma. The patients ranged in age from 3 to 21. Half were age 14 or younger.
Patients who relapsed received additional therapy. Researchers said it is too soon to know if these patients will have the same long-term survival rates as those whose did not relapse. The additional treatment included intensive chemotherapy followed by a stem cell transplant using the patient's own blood-producing stem cells.
###
St. Jude Children's Research Hospital
Since opening 50 years ago, St. Jude Children's Research Hospital has played a pivotal role in pushing overall U.S. pediatric cancer survival rates from 20 to 80 percent. Founded by the late entertainer Danny Thomas, St. Jude is the first and only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. St. Jude is also a leader in research and treatment of life-threatening blood disorders and infectious diseases in children. No family ever pays St. Jude for the care their child receives. To learn more, visit www.stjude.org. Follow us on Twitter @StJudeResearch.
The Stanford University School of Medicine
The Stanford University School of Medicine consistently ranks among the nation's top medical schools, integrating research, medical education, patient care and community service. For more news about the school, please visit http://mednews.stanford.edu.
Lucile Packard Children's Hospital
Lucile Packard Children's Hospital at Stanford is an internationally recognized 311-bed hospital, research center and leading regional medical network providing the full complement of services for the health of children and expectant mothers. In partnership with the Stanford University School of Medicine, our world-class doctors and nurses deliver innovative, family-centered care in every pediatric and obstetric specialty, tailored to every patient. Packard Children's is annually ranked as one of the nation's best pediatric hospitals by U.S. News & World Report and is the only Northern California children's hospital with specialty programs ranked in the U.S. News Top 10. Learn more about us at www.lpch.org and about our continuing growth at growing.lpch.org. Like us on Facebook, watch us on YouTube and follow us on Twitter.
Dana-Farber/Children's Hospital Cancer Center
Since 1947, Boston Children's Hospital and Dana-Farber Cancer Institute have provided comprehensive care for children and adolescents with cancer through Dana-Farber/Children's Hospital Cancer Center. The two Harvard Medical School affiliates share a clinical staff that delivers inpatient care at Boston Children's and outpatient therapies at Dana-Farber's Jimmy Fund Clinic. The Boston Children's inpatient pediatric cancer service has 33 beds, including 13 designated for stem cell transplant patients.
Stanford/Packard Children's Media Relations Contacts:
Stanford University School of Medicine news pager
(650) 723-8222, pager ID #25314
Robert Dicks
(650) 497-8364
rdicks@lpch.org
Dana-Farber/Children's Hospital Cancer Center Media Relations Contact:
Bill Schaller
(617) 632-5357
william_schaller@dfci.harvard.edu
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
A profile of artist Miguel Perez Lem by Eliza French made the Top in A&E in 2012. (Luis Gomez Photos)
It?s that time again? a look back before we start 2013. Like last December, we?re listing the most-read stories on Borderstan by category. Today are the Top 10 from the Arts and Entertainment section.
Remember that the web is forever, so they say. Posted stories continue to get hits long after originally going up on the site. As a result, some of the most-read stories for the year were sometimes published the year before ? especially if they were published late the year before.
Top 10 Borderstan A&E Stories of 2012
These Arts and Entertainment stories were Top 10 most read in 2012 on?Borderstan.com. Assistant Editor Rachel Nania and Editor Luis Gomez each had three of the Top 10 stories while Bordertan Movie Fan Mary Burgan had two, and arts writer Eliza French rounded out the list.
Margin Call?a Great Explanation of Financial Crisis, Great Recession??(Mary Burgan)
Tropicalia: A Psychedelic Buena Vista Social Club at 14th and U?Luis Gomez)
Illuminate Connecticut Avenue: DCCAH Calls For Public Art Entries?(Rachel Nania)
A Bastille Day Salute: 10 French Films to See?(Mary Burgan)
Ibero-America Film Showcase 2012 Starts Jan. 19?(Luis Gomez)
Adams Morgan Picked as One of ?Prettiest Painted Places? in U.S.?(Rachel Nania)
Pics from 17th Street Festival: Did We See You There??(Luis Gomez)
Tuesday at Stead Park Field: Watch ?Grease? Under the Stars?(Borderstan)
Tonight! It?s the Annual 17th Street High Heel Race?(Rachel Nania)
Miguel Perez Lem: An International Artist with an Eclectic Approach?(Eliza French)
Get an?RSS Feed for all Borderstan stories?or?subscribe to Borderstan?s daily email newsletter.
MIAMI (AP) ? When the Miami Heat players and coaches showed up for work Saturday morning, basketball was secondary.
Newtown was the focus.
Friday's massacre at an elementary school in Newtown, Conn., was the primary topic of discussion among the Heat, even though they were gathered to finish prepping for a Saturday night game against Washington. It's rare for anything to overshadow basketball on the Heat practice court, but clearly, this was not going to be a typical day.
"Basketball, this is nothing," Heat forward LeBron James said. "These games are nothing compared to when you have a tragedy like that. It sucks that sometimes you need a tragedy to put things back in perspective, to appreciate what you have. But it does that to people. It's unfortunate that you have to have something like that to understand what's really important and some things that aren't important at all. Family is the No. 1 important thing in life."
It's likely that many Heat players and coaches had never heard of Newtown before Friday.
That doesn't mean they weren't affected, like countless others. Moments of silence were observed before many games.
In Memphis before tipoff of a college basketball game against Louisville, a moment of silence was observed for the victims and for 32-year-old Memphis police officer Martoiya Lang, a mother of four children, who was shot and killed on Friday. Public address announcer Chuck Roberts struggled and his voice choked up a bit as he said the Memphis officer's name. And he finished after the moment ended with "Amen."
In England, the Queens Park Rangers soccer team wore black armbands at the request of its players during a Premier League match against Fulham. Chelsea captain John Terry on Instagram said "So So Sad" beneath a picture of a candle, and he urged prayers for school. Manchester City captain Vincent Kompany tweeted: "Giving guns to everyone to 'protect' their home or fighting to get rid of all the guns? How many more Newtons will it take?"
Moments of silence were everywhere, from a minor-league hockey game in Hershey, Pa.; a U.S. women's soccer exhibition match in Boca Raton, Fla.; and at golf's Father-Son Challenge in Orlando, Fla., where all players and caddies wore black ribbons to honor the victims.
More tributes ? many more ? are coming from the sports world over the next few days. It's expected that all NFL games this weekend will be preceded by tributes, such as moments of silence and helmet decals. The New York Giants and New York Jets both plan to wear the letters S.H.E.S., for Sandy Hill Elementary School, on their helmets this weekend. And the New England Patriots will light flares for each of the 26 people killed at the school.
"Our thoughts and prayers are with all the people impacted by that tragedy," Jets coach Rex Ryan said Saturday. "It's, wow, it's amazing. ... Just a horrific deal that happened there."
The Heat also held a moment of silence Saturday night, with many players being accompanied on the court by their children. Chris Bosh held his son, Jackson, tightly against his chest.
Heat coach Erik Spoelstra has shopped at the Clackamas Town Center, a mall in his native Oregon where a gunman killed two people Tuesday and then himself. One of Dwyane Wade's nephews was shot last March in Chicago, where gun violence is a major topic of discussion. Ray Allen attended the University of Connecticut, still calls it "my state" and expressed shock as he tried to collect information about Friday's events.
"It's still on my mind. I'm really emotional about it. My eyes water up a little bit just thinking about it right now. Your kids are what you live for," Heat forward Udonis Haslem said, his voice barely above a whisper.
Spoelstra typically comes into the Heat interview room after game-day practices and makes a brief statement about injury situations or what the team worked on that particular day.
He started his remarks Saturday by talking about Newtown, nothing about the Heat or the Wizards.
"We talked about it as a team today and our thoughts and prayers are with the families and the community," Spoelstra said. "Horrific tragedy in Connecticut. We took some time to give our thoughts and prayers to them.
"It's despicable," he added. "It's a horrific tragedy. And it doesn't matter whether you have family or not or kids or not, you can't relate to a tragedy like that."
Spoelstra said he monitored news reports on the Internet until late Friday night. James was getting updated on the day's events even as the Heat were visiting sick children in a pair of Miami hospitals on Friday afternoon, after which he immediately went home and hugged his own sons, neither of whom is likely old enough to comprehend what took place inside that Newtown school.
"Just having two kids of my own, in elementary, I could not imagine sending them off to school and them not returning," James said.
Haslem has three sons, and said he tried telling his oldest boy that "things happen in this world that we have no control over."
He's all-too-familiar with the grieving process, having lost close friends and relatives over the years. Still, Haslem insisted that he cannot comprehend what the families in Newtown feel, especially with this all happening so close to Christmas.
"You take it one day at a time. You're never going to forget about it. Time heals the wounds, slowly," Haslem said. "I still grieve over my friends. I still grieve over my family members I've lost. Slowly, slowly, it gets a little bit ? not a lot ? but a little bit easier.
"We love the money, we love the fame, we love the sport, but at the end of the day, we do this for our kids and the legacy to give them things you never had," Haslem said. "If it was about us, a lot of us would have retired after our first contract. You do this for your kids. Your kids are everything. My three kids are my heart. I just imagine someone taking my heart away from me. Might as well kill me."
___
AP Sports Writer Dennis Waszak Jr. in New York contributed to this report.
Must have a Bachelor's degree and be open to 100% travel (M-F).
Looking for a Network Communications candidate that does architecture of Cisco VOIP/Voice solutions?- not just administrations. Need 2+ year designing and implementing Voice/VOIP solutions. Need VOIP, IVR, CTI and either Cisco, VOIP, Avaya or Genesys. Need all areas of design and implementation, not just helpdesk/support people. Experts at Front End design and deployment or Back End/routing Voice/VOIP experience. Must have excellent soft skills and job stability.
Develop network detailed designs in the following areas: Voice (VoIP, unified communications) and Contact Center (IVR Self Service, Multi-media Routing, CTI and Application Integration)
Perform assessments of existing client contact center infrastructure and document "as-is" environments, as required
Implement contact center infrastructure (Hands-on engineering, configuration, testing, operations support)
Work with clients to develop high-level technology strategies with supporting roadmap and business case support
Plan, organize, and manage contact center design and or implementation projects
Organize project work into client presentations outlining findings and recommendations.
Project management activities including work planning, status reporting, client relationship management, and project financial management.
Establish and maintain good working relationships with clients.
Participate in internal and client-facing meetings, prepare reports and presentations
Develop internal white papers and knowledge capital on contact center technology topics
100% Travel
Basic Qualifications:
Minimum two years experience designing and deploying voice and contact center capabilities
Minimum two years experience with one of the following: Voice Over IP (VOIP), Call Routing, Computer Telephony Integration (CTI), Voice Portal and Interactive Voice Response (IVR) and Contact Center Performance Reporting
Hands-on experience with one or more of the following vendor products: Cisco IPCC/CVP, Avaya Contact Center, Genesys CIM/GVP
The International Tribunal of the Sea in Hamburg has ruled that Ghana must return Argentina's naval vessel, the ARA Libertad, immediately?MercoPress reports.?
The boat has been impounded since October 2nd, when hedge fund manager Paul Singer got a Ghanaian Court to rule that the boat be detained because of Argentina's outstanding debt to him, and a number of other hedge fund managers. A bail was set for $20 million.
As the boat languished in the Port of Tema, Argentina had it out with Singer in a New York Courtroom. The country refuses to pay Singer and other plaintiffs $1.3 billion in outstanding sovereign debt that they bought in 2001, citing the fact that, unlike other bondholders, the plaintiffs did not take the opportunity to restructure their debt in 2005 and 2010.
The majority of bondholders accepted a 70% haircut on their investment, but Singer is holding out because he and his fellows want to be paid in full. That's why he had Argentina's vessel impounded as collateral, and that's why Argentina refers to him, and other holdouts as "vulture" funds.
As that case went to an Appeals Court, there was conflict on the ARA Libertad. At one point the 40-plus sailors on the boat drew their guns when Ghanaian port officials tried to force the them to move the boat to a sleepier part of the port.
Argentina filed suit with the International Tribunal of the Sea to get their vessel back in mid November. The Court said that it would decide on the matter by December 15th, and Judge Shunji Jenai's ruling was firm (from MercoPress):
?Ghana must release with no conditions the frigate, guaranteeing that the vessel, its captain and the crew can leave the port of Tema and ensuring their provision? said the unanimous ruling...
The UN court considered a statement from Argentina that attempts by authorities in Ghana to move the ship ?could lead to an escalation? which could lead to ?incidents which could endanger life? Judge Yanai said.
The court also considered Argentina's claim that the ship could not be maintained correctly during its arrest and that the vessel' safety could so be endangered.
Now there are a few things that need to happen before the boat heads back to Argentina. Both Ghana and Argentina must submit a report on paying their own costs by December 22nd, and the Tribunal will make more decisions about the dispute then.
Meanwhile, the New York Appeals Court will make additional rule on the fight between Argentina and bondholders in February.